Risk factor
Low price volatility
Profitability factor
Excellent dividends
About
Fleury S.A., together with its subsidiaries, provides medical services in the diagnostic, treatment, clinical analysis, health management, medical care, orthopedics, and ophthalmology areas in Brazil. The company operates through three segments: Diagnostic Medicine, Integrated Medicine, and Dental. It provides laboratory and image exam, diagnostic information, check-up and reference laboratory, genomics, clinic day, center of infusions,...
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. In particular, the stock is reasonably priced on P/E, 'cheap' on EV/EBITDA, undervalued on
Target Price
The average target price of FLRY3.SA is 16 and suggests 9% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
